Literature DB >> 301145

Modulatory effects on immunoglobulin synthesis and secretion by lymphocytes from immunodeficient patients.

S A Schwartz, Y S Choi, L Shou, R A Good.   

Abstract

Incubation of peripheral lymphocytes (PBL) from normal donors with pokeweek mitogen (PWM) induced terminal differentiation by B lymphocytes to immunoglobulin (Ig) synthesizing and secreting plasma cells. B cells from hypogammaglobulinemic patients with different primary immunodeficiencies failed to undergo functional differentiation after similar treatment with PWM. Co-cultures of BL from normal donors and hypogammaglobulinemic patients often resulted in deviations, both positive and negative, from expected levels of PWM-stimulated intracellular Ig biosynthesis. Suppression of B-cell differentiation was manifested by PBL from patients with several different primary immunodeficiencies, including infantile sex-linked agammaglobulinemia. Immunoregulatory activities were noted to vary with the normal donor used in co-culture experiments and with time. Cell populations that were active in influencing B-cell differentiation to functional plasma cells did not have an appreciable modulatory effect on T-lymphocyte responses to mitogens. These observations may provide a functional subclassifications for immunoregulatory cells in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301145      PMCID: PMC372331          DOI: 10.1172/JCI108742

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Transplantation studies in patients with agammaglobulinemia.

Authors:  R A GOOD; R L VARCO; J B AUST; S J ZAK
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

2.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

Review 4.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

5.  Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation.

Authors:  M D Cooper; A R Lawton; D E Bockman
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Serological precipitation method for studying biosynthesis and secretion of immunoglobulins by human peripheral blood lymphocytes.

Authors:  Y S Choi
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

8.  Induction of specific suppressor T cells in vitro.

Authors:  D D Eardley; R K Gershon
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

9.  Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

Authors:  J J Twomey; A H Laughter; S Farrow; C C Douglass
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Infectious agammaglobulinemia: transmission of immunodeficiency with grafts of agammaglobulinemic cells.

Authors:  R M Blaese; P L Weiden; I Koski; N Dooley
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  17 in total

1.  Free immunoglobulin light chain synthesis by lymphocytes from patients with hypogammaglobulinaemia.

Authors:  J Gordon; J L Smith
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

2.  B-cell function in common variable immunodeficiency: suppression of in vitro anti-sheep erythrocytes antibody production by T cells and monocytes.

Authors:  S Pollack; Y Reisner; B Koziner; R A Good; M K Hoffman
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

3.  Plasma cell infiltration of the small bowel: lack of evidence for a non-secretory form of alpha-heavy chain disease.

Authors:  N H Gilinsky; A S Mee; D W Beatty; B H Novis; G Young; S Price; L R Purves; I N Marks
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

4.  Polyclonal and antigen-specific B-cell responses in patients with common variable immunodeficiency.

Authors:  S G Pahwa; M K Hoffman; R N Pahwa; R A Good
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

5.  Lymphocyte subpopulations in primary immunodeficiency disorders.

Authors:  S Gupta
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

6.  Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM.

Authors:  D Levitt; H Ochs; R J Wedgwood
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

7.  Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.

Authors:  L Mayer; S M Fu; C Cunningham-Rundles; H G Kunkel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

9.  Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. III. Common variable immunodeficiency.

Authors:  D A Cooper; P Hansen; M Duckett; J B Ziegler; R Penny
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

10.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.